NCT02535845|TerminatedResultsDMC
Study Stopped
Halted early due to poor accrual and lack of time to receive intervention procedures adjacent to a clinic visit post randomization.
Loading search results
Halted early due to poor accrual and lack of time to receive intervention procedures adjacent to a clinic visit post randomization.
Sponsor study identifier
Secondary identifiers
NIH
interventional
22
1 country
1
Study Start
December 21, 2017
Actual (reported)Primary Completion
January 31, 2019
Actual (reported)Study Completion
January 31, 2019
Actual (reported)HPV vaccine coverage among adolescents in the US is suboptimal. This is particularly true among traditionally underserved adolescents. Few parent-targeted interventions have focused on the parental decision-making process. Self-persuasion, generating one's own arguments for engaging in a behavior, may be an effective means to influence parents' motivation to vaccinate their children. In a three-phase study, investigators are using quantitative and qualitative research methods to develop and refine a tablet-based self-persuasion intervention for parents who are undecided about the HPV vaccine. This clinical trial submission focuses on the third phase of the study (the second stage is also registered in clinical trials).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 31, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 26, 2015
Actual (reported)August 31, 2015
Actual (reported)December 21, 2017
Actual (reported)January 31, 2019
Actual (reported)January 31, 2019
Actual (reported)January 30, 2024
Actual (reported)HPV Vaccination Behavior Documented in Electronic Health Record, Initiation
Number of parents who decided to start the HPV vaccine three dose series and got their child vaccinated within 30 days of the study appointment as evidenced by documentation in the child's electronic medical record.
30 days
HPV Vaccination Behavior Documented in Electronic Medical Record, Completion
15 months
Active Parent Participation During Clinical Encounter
1 day
HPV information plus self-persuasion intervention in a tablet-based application (Project Voice)
HPV information only in a tablet-based application (HPV Informational Video)
Project Voice tablet-based intervention plus informational video
Informational video only
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
UT Southwestern Medical Center
Dallas, Texas, 75390-8557, United States
Tiro JA, Lee SC, Marks EG, Persaud D, Skinner CS, Street RL, Wiebe DJ, Farrell D, Bishop WP, Fuller S, Baldwin AS. Developing a Tablet-Based Self-Persuasion Intervention Promoting Adolescent HPV Vaccination: Protocol for a Three-Stage Mixed-Methods Study. JMIR Res Protoc. 2016 Jan 29;5(1):e19. doi: 10.2196/resprot.5092.
Jasmin A Tiro, PhD
University of Texas Southwestern Medical Center
Austin S Baldwin, PhD
Southern Methodist University
22 participants (actual enrollment reported by the registry).
First Submitted
August 26, 2015
First Posted
August 31, 2015
Study Start
December 21, 2017
Actual (reported)The STOP-HPV Scale Up Study
Contact the study team to confirm eligibility.
Primary Completion
January 31, 2019
Actual (reported)Study Completion
January 31, 2019
Actual (reported)Last Updated
January 30, 2024
Results First Posted
January 30, 2024
Record last verified: 2024-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: